Gujarat Kidney And Super Speciality Limited IPO
BBMainboardBSE,NSEListed
Listed at
120
+5.26%
Gujarat Kidney And Super Speciality Limited IPO is a Mainboard book building IPO. Issue size is ₹250.80 Cr. Price band is ₹108 to ₹114 per share. Minimum investment is ₹14,592. Lot size is 128 shares. Open from 22 Dec 2025 to 24 Dec 2025. Allotment on 26 Dec 2025. Listing on 30 Dec 2025 at BSE,NSE. Managed by Nirbhay Capital Services Pvt.Ltd Registrar: MUFG Intime India Private Limited (Link Intime). Key details for GMP, subscription, price, allotment, and listing in one place.
Gujarat Kidney And Super Speciality Limited IPO overview
Gujarat Kidney And Super Speciality Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Price band
₹108 to ₹114
Lot size
128 shares / lot
Min investment
₹14,592
Issue open – close
22 Dec 2025 → 24 Dec 2025
Gujarat Kidney And Super Speciality Limited IPO important dates
Issue Opens
22 Dec 2025
Issue Closes
24 Dec 2025
Allotment
26 Dec 2025
Listing
30 Dec 2025
Gujarat Kidney And Super Speciality Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 128 | ₹14,592 |
| Retail (Max) | 13 | 1,664 | ₹1,89,696 |
| S-HNI (Min) | 14 | 1,792 | ₹2,04,288 |
| S-HNI (UPI) | 34 | 4,352 | ₹4,96,128 |
| S-HNI (Max) | 68 | 8,704 | ₹9,92,256 |
| B-HNI (Min) | 69 | 8,832 | ₹10,06,848 |
Cut‑off within the price band is set after book‑building when applicable. SME issues often require at least two lots; mainboard retail typically bids one lot at cut‑off.
Quick Profit Calculator for Gujarat Kidney And Super Speciality Limited IPO
Pre-filled: Issue Price = ₹114, Lot Size = 128 shares, Listing Price = ₹120
| Category | Lots | Investment | At listing | Profit |
|---|---|---|---|---|
| Retail (Min) | 1 | ₹14,592 | ₹120 | +₹768 |
| Retail (Max) | 13 | ₹1,89,696 | ₹120 | +₹9,984 |
| S-HNI (Min) | 14 | ₹2,04,288 | ₹120 | +₹10,752 |
| S-HNI (UPI) | 34 | ₹4,96,128 | ₹120 | +₹26,112 |
| S-HNI (Max) | 68 | ₹9,92,256 | ₹120 | +₹52,224 |
| B-HNI (Min) | 69 | ₹10,06,848 | ₹120 | +₹52,992 |
Profit based on the official listing price for each investor category.
About Gujarat Kidney And Super Speciality Limited IPO
From the company / RHP narrative.
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India.
The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.
The company's hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).
Gujarat Kidney And Super Speciality Limited IPO FAQs
A quick overview of key terms, dates, and how to track this IPO.
What is Gujarat Kidney And Super Speciality Limited IPO?
Gujarat Kidney And Super Speciality Limited IPO is a public issue where the company offers its shares to investors through the stock exchange, allowing retail, HNI, and institutional participation.
What is the IPO price band of Gujarat Kidney And Super Speciality Limited IPO?
The IPO price band of Gujarat Kidney And Super Speciality Limited IPO is ₹₹108 to ₹114 per share, as mentioned in the issue details.
What is the minimum investment required for Gujarat Kidney And Super Speciality Limited IPO?
The minimum investment in Gujarat Kidney And Super Speciality Limited IPO is ₹14,592, based on the applicable lot size for retail investors.
What is the lot size of Gujarat Kidney And Super Speciality Limited IPO?
The lot size of Gujarat Kidney And Super Speciality Limited IPO is 128 shares per lot, and applications must be made in multiples of this lot size.
What are the opening and closing dates of Gujarat Kidney And Super Speciality Limited IPO?
Gujarat Kidney And Super Speciality Limited IPO opens on 22 Dec 2025 and closes on 24 Dec 2025, as per the announced schedule.
What is Gujarat Kidney And Super Speciality Limited IPO subscription status?
Gujarat Kidney And Super Speciality Limited IPO subscription status shows the level of demand across retail, HNI, and institutional investor categories during the issue period.
What is Gujarat Kidney And Super Speciality Limited IPO GMP today?
Gujarat Kidney And Super Speciality Limited IPO GMP (Grey Market Premium) today is around ₹TBA, reflecting current grey market activity before listing.
Is Gujarat Kidney And Super Speciality Limited IPO GMP positive or negative?
Gujarat Kidney And Super Speciality Limited IPO GMP is currently subject to change, based on prevailing grey market trends. GMP may change over time.
What does Gujarat Kidney And Super Speciality Limited IPO GMP indicate for listing?
A positive Gujarat Kidney And Super Speciality Limited IPO GMP may indicate market interest ahead of listing, while actual listing performance depends on subscription response and market conditions.
When is Gujarat Kidney And Super Speciality Limited IPO listing date?
The expected listing date of Gujarat Kidney And Super Speciality Limited IPO is 30 Dec 2025, subject to completion of the allotment process.
Where can I check Gujarat Kidney And Super Speciality Limited IPO allotment status?
Gujarat Kidney And Super Speciality Limited IPO allotment status can be checked online once the allotment process is completed using application or PAN details.
Can Gujarat Kidney And Super Speciality Limited IPO subscription and GMP change before listing?
Yes, Gujarat Kidney And Super Speciality Limited IPO subscription figures and GMP may change during the issue period and before listing based on market activity.
Gujarat Kidney And Super Speciality Limited IPO Ratings & reviews
Community ratings and reviews — not financial advice.
No ratings yet — be the first to share your experience.
Loading ratings…